# MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i>

_BIOCELL · Xiaobiao Ma, Jiamin Liu, Dan Liu et al. · 2026_

Canonical: https://diginpl.com/books/paper-biocell-2026-087405
Last updated: 2026-10-16

## Quick facts

- **Author:** Xiaobiao Ma; Jiamin Liu; Dan Liu; Yongjiang Yao; Li Li ([Crossref](https://doi.org/10.32604/biocell.2026.087405))
- **Published:** 2026 ([Crossref](https://doi.org/10.32604/biocell.2026.087405))
- **Publisher:** Tech Science Press ([Crossref](https://doi.org/10.32604/biocell.2026.087405))
- **Journal:** BIOCELL ([Crossref](https://doi.org/10.32604/biocell.2026.087405))
- **DOI:** 10.32604/biocell.2026.087405 ([Crossref](https://doi.org/10.32604/biocell.2026.087405))

## Questions

**Who wrote MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i>?**  
MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i> was written by Xiaobiao Ma, Jiamin Liu, Dan Liu, Yongjiang Yao.

**When was MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i> first published?**  
MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i> was first published in 2026.

## Sources

- [Publisher record (DOI, via Crossref)](https://doi.org/10.32604/biocell.2026.087405)

## Licence and attribution

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/biocell.2026.087405.

## Cite this page

"MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i>". DigiNepal. Last updated 16 October 2026. https://diginpl.com/books/paper-biocell-2026-087405. Retrieved 14 November 2026.